Innospec Inc. (NASDAQ:IOSP) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC trimmed its holdings in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) by 87.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,352 shares of the specialty chemicals company's stock after selling 30,020 shares during the quarter. Mutual of America Capital Management LLC's holdings in Innospec were worth $536,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of IOSP. Stonegate Investment Group LLC purchased a new stake in Innospec during the 4th quarter worth approximately $204,000. Nisa Investment Advisors LLC grew its position in Innospec by 5.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 1,960 shares of the specialty chemicals company's stock worth $242,000 after purchasing an additional 100 shares during the last quarter. Tocqueville Asset Management L.P. purchased a new stake in shares of Innospec during the third quarter worth approximately $203,000. Ballentine Partners LLC acquired a new stake in Innospec in the fourth quarter valued at about $269,000. Finally, Evergreen Capital Management LLC lifted its holdings in Innospec by 10.2% in the third quarter. Evergreen Capital Management LLC now owns 2,210 shares of the specialty chemicals company's stock valued at $226,000 after acquiring an additional 205 shares during the period. Institutional investors and hedge funds own 96.64% of the company's stock.

Insider Activity

In other Innospec news, Director Leslie J. Parrette purchased 410 shares of Innospec stock in a transaction dated Thursday, February 22nd. The shares were bought at an average cost of $123.96 per share, for a total transaction of $50,823.60. Following the transaction, the director now owns 3,620 shares in the company, valued at approximately $448,735.20. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In other Innospec news, Director Leslie J. Parrette acquired 410 shares of the firm's stock in a transaction that occurred on Thursday, February 22nd. The stock was acquired at an average cost of $123.96 per share, with a total value of $50,823.60. Following the acquisition, the director now directly owns 3,620 shares of the company's stock, valued at approximately $448,735.20. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, VP Philip John Boon sold 3,715 shares of Innospec stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $122.07, for a total value of $453,490.05. Following the sale, the vice president now directly owns 18,516 shares in the company, valued at approximately $2,260,248.12. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 36,500 shares of company stock worth $4,532,959. 1.35% of the stock is currently owned by corporate insiders.

Innospec Price Performance

Innospec stock traded down $0.91 during mid-day trading on Wednesday, reaching $122.04. The company had a trading volume of 74,262 shares, compared to its average volume of 88,536. Innospec Inc. has a 1 year low of $91.74 and a 1 year high of $131.18. The company has a market capitalization of $3.04 billion, a P/E ratio of 21.91 and a beta of 1.10. The stock's 50-day simple moving average is $124.42 and its 200-day simple moving average is $115.70.

Innospec (NASDAQ:IOSP - Get Free Report) last announced its earnings results on Tuesday, February 13th. The specialty chemicals company reported $1.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.59 by $0.25. The firm had revenue of $494.70 million for the quarter, compared to analyst estimates of $479.47 million. Innospec had a net margin of 7.14% and a return on equity of 13.69%. Innospec's revenue was down 3.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.20 earnings per share. On average, equities analysts forecast that Innospec Inc. will post 6.77 EPS for the current fiscal year.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.